leadership at MIT’s AI Lab. As former operators, we understand the intricacies of how enterprise AI software is justified, purchased, and deployed, providing us with unique insights into the challenges and opportunities our portfolio companies face. We combine technical, corporate, investment banking, and venture experience.

The six key investment verticals are Healthcare, Life Sciences, Manufacturing, Food Supply, Energy/Natural Resources, and Public Safety/Cybersecurity. Our investment approach is targeting Series A companies with recurring revenue and measurable impact, delivering returns well above traditional software solutions. The firm makes series A initial investments with capital reserved for follow-on series B rounds and will also consider late seed stage investments.